EXHIBIT 8

Dr. Reddy’s Laboratories Limited

Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries and joint ventures as of March 31, 2021:

Name of the subsidiary/joint venture	Country of Incorporation	Percentage of Direct/Indirect Ownership Interest
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd.	Malaysia	100%(3)
Aurigene Discovery Technologies, Inc.	U.S.A.	100%(3)
Aurigene Discovery Technologies Limited	India	100%
Aurigene Pharmaceutical Services Limited (from September 16, 2019)	India	100%(3)
beta Institut gemeinnützige GmbH	Germany	100%(8)
betapharm Arzneimittel GmbH	Germany	100%(8)
Cheminor Investments Limited	India	100%
Cheminor Employees Welfare Trust	India	Refer to below footnote(16)
Chirotech Technology Limited	United Kingdom	100%(2)(5)
Dr. Reddy’s Research Foundation	India	Refer to below footnote(16)
Dr. Reddy's Employees ESOS Trust (from July 27, 2018)	India	Refer to below footnote(16)
Dr. Reddy’s Farmaceutica Do Brasil Ltda.	Brazil	100%
Dr. Reddy’s Laboratories (EU) Limited	United Kingdom	100%(10)
Dr. Reddy’s Laboratories (Proprietary) Limited	South Africa	100%(10)
Dr. Reddy’s Laboratories (UK) Limited	United Kingdom	100%(5)
Dr. Reddy’s Laboratories Canada, Inc.	Canada	100%(10)
Dr. Reddy's Laboratories Chile SPA.	Chile	100%(10)
Dr. Reddy’s Laboratories, Inc.	U.S.A.	100%(10)
Dr. Reddy’s Laboratories Japan KK	Japan	100%(10)
Dr. Reddy’s Laboratories Kazakhstan LLP	Kazakhstan	100%(10)
Dr. Reddy’s Laboratories Louisiana, LLC	U.S.A.	100%(6)
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd.	Malaysia	100%(10)
Dr. Reddy’s Laboratories New York, LLC	U.S.A.	100%(1)
Dr. Reddy's Laboratories Philippines Inc. (from May 9, 2018)	Philippines	100%(10)
Dr. Reddy’s Laboratories Romania S.R.L.	Romania	100%(10)
Dr. Reddy’s Laboratories SA	Switzerland	100%
Dr. Reddy's Laboratories Taiwan Limited	Taiwan	100%(10)
Dr. Reddy's Laboratories (Thailand) Limited (from June 13, 2018)	Thailand	100%(10)
Dr. Reddy’s Laboratories, LLC	Ukraine	100%(10)
Dr. Reddy’s New Zealand Limited	New Zealand	100%(10)
Dr. Reddy’s S.R.L.	Italy	100%(11)
Dr. Reddy's Bio-Sciences Limited	India	100%
Dr. Reddy's Laboratories (Australia) Pty. Limited	Australia	100%(10)
Dr. Reddy's Laboratories S.A.S.	Colombia	100%(10)
Dr. Reddy's Research and Development B.V. (formerly Octoplus B.V.)	Netherlands	100%(12)
Dr. Reddy's Venezuela, C.A.	Venezuela	100%(10)
Dr. Reddy’s (WUXI) Pharmaceutical Company Limited	China	100%(10)
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited (from August 19, 2020)	China	100%(10)
DRANU LLC	U.S.A.	50%(14)(17)
DRES Energy Private Limited	India	26%(15)
DRL Impex Limited	India	100%(13)
Dr. Reddy's Laboratories B.V. (formerly Eurobridge Consulting B.V.)	Netherlands	100%(12)
Dr. Reddy’s Formulations Limited (from March 11, 2021)	India	100%
Idea2Enterprises (India) Private Limited	India	100%
Imperial Credit Private Limited	India	100%
Industrias Quimicas Falcon de Mexico, S.A. de CV	Mexico	100%
Kunshan Rotam Reddy Pharmaceutical Co. Limited	China	51.33%(4)
Lacock Holdings Limited	Cyprus	100%(10)
OOO Dr. Reddy's Laboratories Limited	Russia	100%(10)
OOO DRS LLC	Russia	100%(9)
Promius Pharma, LLC	U.S.A.	100%(6)
Reddy Holding GmbH	Germany	100%(10)

Name of the subsidiary/joint venture	Country of Incorporation	Percentage of Direct/Indirect Ownership Interest
Reddy Netherlands B.V.	Netherlands	100%(10)
Reddy Pharma Iberia S.A.U.	Spain	100%(10)
Reddy Pharma Italia S.R.L.	Italy	100%(7)
Reddy Pharma SAS	France	100%(10)
Svaas Wellness Limited (formerly Regkinetics Services Limited)	India	100%

⁽¹⁾ Indirectly owned through Dr. Reddy’s Laboratories, Inc. (from October 29, 2020), formerly a subsidiary of Dr. Reddy’s Laboratories SA. Also, conversion from corporation to limited liability company is effective October 30, 2020.

⁽²⁾ Entity under liquidation.

⁽³⁾ Indirectly owned through Aurigene Discovery Technologies Limited.

⁽⁴⁾ Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements.

⁽⁵⁾ Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.

⁽⁶⁾ Indirectly owned through Dr. Reddy’s Laboratories Inc.

⁽⁷⁾ Indirectly owned through Lacock Holdings Limited.

⁽⁸⁾ Indirectly owned through Reddy Holding GmbH.

⁽⁹⁾ Indirectly owned through OOO Dr. Reddy's Laboratories Limited.

⁽¹⁰⁾ Indirectly owned through Dr. Reddy’s Laboratories SA.

⁽¹¹⁾ Indirectly owned through Reddy Pharma Italia S.R.L.

⁽¹²⁾ Indirectly owned through Reddy Netherlands B.V.

⁽¹³⁾ Indirectly owned through Idea2Enterprises (India) Pvt. Limited.

⁽¹⁴⁾ DRANU LLC is consolidated in accordance with guidance available in IFRS 10, “Consolidated financial statements”.

⁽¹⁵⁾ Accounted in accordance with IFRS 11, “Joint Arrangements”.

⁽¹⁶⁾ The Company does not have any equity interests in this entity, but has significant influence or control over it.

⁽¹⁷⁾ Pursuant to the sale of the membership interests in DRANU, LLC, it ceased to be a joint venture effective March 31, 2021.